Citius Oncology, Inc. CTOR Stock Issued During Period Value Proceeds From Exercise Of Prefunded Warrants
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept ctor:StockIssuedDuringPeriodValueProceedsFromExerciseOfPrefundedWarrants.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s stock issued during period value proceeds from exercise of prefunded warrants.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s stock issued during period value proceeds from exercise of prefunded warrants?
- Citius Oncology, Inc. (CTOR) reported stock issued during period value proceeds from exercise of prefunded warrants of $818 in Q1 2026.